Methylated ctDNA as a biomarker for detecting previously undetectable clinically significant somatic mutations.
Year: 2023
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: BillionToOne (United States), Moores Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4379283296
